GLAXOSMITHKLINE, S.A. secures contract for Pharmaceutical products Supply of the medicine Belimumab 200 mg injectable 1 ml pre-filled pen exclusive medicine marketed by Glaxosmithkline SA destined for centers dependent on the Health Service of the Balearic Islands

Spain, March 25 -- Spain based GLAXOSMITHKLINE, S.A. has secured contract from Servicio de Salud de las Illes Balears for Pharmaceutical products Supply of the medicine Belimumab 200 mg injectable 1 ml pre-filled pen exclusive medicine marketed by Glaxosmithkline SA destined for centers dependent on the Health Service of the Balearic Islands. The value of the contract is worth 124701973 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....